TA-65® is a trademarked, plant-based approach from T.A. Sciences® of Scottsdale, Arizona, which has become internationally renowned in connection with telomeres, telomerase, and longevity. According to the manufacturer, T.A. Sciences® was founded in 2002, and the first TA-65® capsules were launched in 2007. This makes TA-65® one of the established names in the international longevity sector today.
What makes TA-65® special?
TA-65® does not simply stand for the plant Astragalus membranaceus, but for a standardized ingredient complex developed from it. It is precisely this combination of botanical origin, modern development, and international recognition that makes TA-65® interesting for many people who are more deeply involved with healthy aging, telomere maintenance, and cellular health.
TA-65® in the context of telomeres and telomerase
The focus is on telomeres, the protective structures at the ends of chromosomes, and telomerase, the enzyme involved in maintaining these structures. TA-65® is described by the manufacturer and in scientific publications as a telomerase-related approach and is therefore thematically classified in the field of longevity, telomeres, and cellular health.
How is TA-65® classified?
For consumers, the clear classification is particularly important: TA-65® is an independent product concept in the longevity sector and should not be equated with general Astragalus. Its long-standing market presence since 2007, the international manufacturer background, and its support by published studies make TA-65® one of the most well-known names in the field of telomere-related longevity concepts.
How does TA-65® work?
Simply put, in scientific and corporate circles, TA-65® is described as an approach associated with the activation of telomerase.
Telomerase is the enzyme that contributes to the maintenance of telomeres. This is precisely why TA-65® is thematically classified in the field of telomere maintenance, cellular health, and longevity.
How long has TA-65® been on the market?
According to publicly available manufacturer information, TA-65® has been on the market since 2007. This long-standing presence underscores that TA-65® is not just a short-term trend, but has been part of the international discussion surrounding telomeres, telomerase, and healthy aging for many years.
This long-standing market presence is accompanied by published preclinical and clinical studies in which TA-65® has been scientifically examined.
